|
Volumn 57, Issue 9, 2004, Pages 943-945
|
What happens to patients with positive tissue transglutaminase and endomysium antibody results in general practice?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ENDOMYSIUM ANTIBODY;
ENZYME ANTIBODY;
PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;
PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;
UNCLASSIFIED DRUG;
ADULT;
ANTIBODY SCREENING;
ARTICLE;
CELIAC DISEASE;
CONSULTATION;
DIAGNOSTIC PROCEDURE;
DUODENUM BIOPSY;
GENERAL PRACTITIONER;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL SOCIETY;
MEDICAL SPECIALIST;
PATIENT REFERRAL;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
UNITED KINGDOM;
AUTOANTIBODIES;
BIOPSY;
CELIAC DISEASE;
FAMILY PRACTICE;
GREAT BRITAIN;
GUIDELINE ADHERENCE;
HUMANS;
INTESTINAL MUCOSA;
PATHOLOGY, CLINICAL;
REFERRAL AND CONSULTATION;
TRANSGLUTAMINASES;
|
EID: 4444384451
PISSN: 00219746
EISSN: None
Source Type: Journal
DOI: 10.1136/jcp.2004.016261 Document Type: Article |
Times cited : (23)
|
References (4)
|